COHANCE vs GRANULES: Stock Comparison

COHANCE LIFESCIENCES vs GRANULES INDIAUpdated 8 Oct 26, 4:08 PM ISTNSE & company filings

COHANCE LIFESCIENCES is the larger company by market capitalisation. COHANCE LIFESCIENCES shows lower leverage, while GRANULES INDIA shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

COHANCE leads 1; GRANULES leads 12 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

COHANCEGRANULES

Valuation lens

What price are you paying?

Market CapContext only
₹16,92,610.59 L Cr
₹22,150 Cr
P/E RatioGRANULES has the lower reading
159.19x
30.11x ✓
P/B RatioGRANULES has the lower reading
4.33x
3.96x ✓
EPSGRANULES has the higher reading
₹2.73
₹7.26 ✓
Book ValueContext only
₹102.03
₹205.21
Dividend YieldGRANULES has the higher reading
0%
0.22% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
COHANCE is the larger company
₹16,92,610.59 L Cr vs ₹22,150 Cr
P/E Ratio
GRANULES has a lower P/E
30.11x vs 159.19x
P/B Ratio
GRANULES has a lower P/B
3.96x vs 4.33x
EPS
GRANULES has higher earnings per share
₹7.26 vs ₹2.73
Dividend Yield
GRANULES has a higher dividend yield
0.22% vs 0%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs -26.3%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs -89%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
84.16% vs 17.33%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCOHANCEGRANULES
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricCOHANCEGRANULES
Live Price₹442.4₹815.05
Day Change-2.87%-3.58%
Volume8.48 L6.71 L
52-Week High₹907.65₹923.65
52-Week Low₹266.7₹529.85
Distance from 52W High-51.26%-11.76%

Valuation

MetricCOHANCEGRANULES
Market Cap₹16,92,610.59 L Cr₹22,150 Cr
P/E Ratio159.19x30.11x
P/B Ratio4.33x3.96x
EPS₹2.73₹7.26
Book Value₹102.03₹205.21
Dividend Yield0%0.22%

Growth

MetricCOHANCEGRANULES
Revenue Growth (TTM YoY)-26.3%22.8%
EPS Growth (TTM YoY)-89%31.3%
Qtr Sales Growth17.33%84.16%
Qtr Profit Growth-3,304.96%150.83%

Profitability & Leverage

MetricCOHANCEGRANULES
ROE3.72%11.7%
ROCE4.26%12.47%
Net Margin7.9%11.15%
Operating Margin10.77%16.76%
Debt to Equity0.04x0.26x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricCOHANCEGRANULES
Promoter Holding0%37.08%▼ 0.59 pp
FII Holding6.5%▲ 0.91 pp20.29%▲ 2.79 pp
DII Holding20.09%▼ 1.7 pp15.4%▼ 0.71 pp
Public Holding15.92%▲ 0.8 pp26.93%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: COHANCE LIFESCIENCES and GRANULES INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.